Samec and co-authors developed and investigated three fusogenic peptide carriers, DIVA3, DIV3H, and DIV3W, composed of amphiphilic core repeats and a cationic poly(D-arginine tail, for delivering siRNA against casein kinase 2 alpha 1 (CSNK2A1) into ovarian cancer cells to reduce the aggressiveness [282]. This evidence concerns the gene CSNK2A1 and ovarian carcinoma.